Prot #32-007: A Phase III, Multinational, Multicenter, Randomized, Double-Masked, Study Assessing the Safety and Efficacy of Intravitreal Injections of DE-109 (three doses) for the Treatment of active, Non-Infectious Uveitis of the Posterior Segment of th

Project: Research project

Project Details

StatusFinished
Effective start/end date11/27/12 → 10/27/16

Funding

  • Santen Inc. (Prot #32-007)